Founders Capital Management (Texas)’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$3K | – | 415 |
|
|
2022
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 298 |
|
|
2021
Q4 | $3K | Sell |
1,000
-5,000
| -83% | -$16.8K | ﹤0.01% | 298 |
|
|
2021
Q3 | $22K | Buy |
6,000
+1,000
| +20% | +$3.77K | 0.02% | 206 |
|
|
2021
Q2 | $18K | Sell |
5,000
-1,000
| -17% | -$3.53K | 0.01% | 221 |
|
|
2021
Q1 | $23K | Buy |
6,000
+2,000
| +50% | +$8.26K | 0.02% | 182 |
|
|
2020
Q4 | $17K | Buy |
+4,000
| New | +$15.4K | 0.01% | 209 |
|
|
2020
Q1 | $11K | Buy |
3,000
+2,000
| +200% | +$9.83K | 0.01% | 211 |
|
|
2019
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 291 |
|
|
2019
Q3 | $4K | Buy |
+1,000
| New | +$4.27K | ﹤0.01% | 307 |
|
|
2019
Q1 | – | Sell |
-6,000
| Closed | -$22K | – | 354 |
|
|
2018
Q4 | $22K | Hold |
6,000
| – | – | 0.02% | 166 |
|
|
2018
Q3 | $17K | Hold |
6,000
| – | – | 0.01% | 198 |
|
|
2018
Q2 | $18K | Hold |
6,000
| – | – | 0.02% | 204 |
|
|
2018
Q1 | $14K | Hold |
6,000
| – | – | 0.01% | 253 |
|
|
2017
Q4 | $18K | Hold |
6,000
| – | – | 0.01% | 226 |
|
|
2017
Q3 | $18K | Hold |
6,000
| – | – | 0.01% | 220 |
|
|
2017
Q2 | $17K | Buy |
6,000
+1,000
| +20% | +$2.11K | 0.02% | 226 |
|
|
2017
Q1 | $10K | Buy |
+5,000
| New | +$9.64K | 0.01% | 297 |
|
Founders Capital Management (Texas)'s BDSI Position: Q2 2022 in Review
Founders Capital Management (Texas) sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2022, closing a stake of 1,000 shares — an estimated $3K sold.
Founders Capital Management (Texas) first reported a position in BDSI in Q1 2017 and held it in 17 quarters. The position peaked at $23K in Q1 2021. 0 funds tracked by Wall St. Rank hold BDSI as of Q2 2022.
- Founders Capital Management (Texas) reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2022 after selling out during the quarter.
- Founders Capital Management (Texas) sold 1,000 BioDelivery Sciences International, Inc. shares in Q2 2022, an estimated $3K.
- Founders Capital Management (Texas) first reported a position in BioDelivery Sciences International, Inc. in Q1 2017 and held it in 17 quarters.
- Founders Capital Management (Texas)'s BioDelivery Sciences International, Inc. position peaked at $23K in Q1 2021.
- 0 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2022.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2022, filed 20 Jul 2022.